221 related articles for article (PubMed ID: 12496356)
1. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
3. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
4. Nucleosomes bind fibroblast growth factor-2 for increased angiogenesis in vitro and in vivo.
Tanner JE; Forté A; Panchal C
Mol Cancer Res; 2004 May; 2(5):281-8. PubMed ID: 15192121
[TBL] [Abstract][Full Text] [Related]
5. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
6. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
Fonseca RJ; Santos GR; Mourão PA
Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
[TBL] [Abstract][Full Text] [Related]
7. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides.
Kronenwett R; Gräf T; Nedbal W; Weber M; Steidl U; Rohr UP; Möhler T; Haas R
Cancer Gene Ther; 2002 Jul; 9(7):587-96. PubMed ID: 12082459
[TBL] [Abstract][Full Text] [Related]
10. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.
Olsen MW; Ley CD; Junker N; Hansen AJ; Lund EL; Kristjansen PE
Neoplasia; 2006 May; 8(5):364-72. PubMed ID: 16790085
[TBL] [Abstract][Full Text] [Related]
12. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
13. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
15. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm.
Mourão PA; Boisson-Vidal C; Tapon-Bretaudière J; Drouet B; Bros A; Fischer A
Thromb Res; 2001 Apr; 102(2):167-76. PubMed ID: 11323028
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
18. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.
García-Fernández L; Halstenberg S; Unger RE; Aguilar MR; Kirkpatrick CJ; San Román J
Biomaterials; 2010 Nov; 31(31):7863-72. PubMed ID: 20674006
[TBL] [Abstract][Full Text] [Related]
20. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
